Scalper1 News
Medical stocks were moving Thursday as the annual San Antonio Breast Cancer Symposium entered its second day with a passel of updates from drug and diagnostics companies. The biggest mover — though in the negative direction — was Puma Biotechnology (PBYI), which was down nearly 15% in afternoon trading on the stock market today after it issued an update on its drug candidate neratinib. Puma presented results from a phase-two trial using neratinib Scalper1 News
Scalper1 News